- Fred's (NASDAQ:FRED) reports sales in March rose 11% to $214.4M. The double-digit growth is tied in part to the addition of the EntrustRx pharmacy business.
- Comparable-store sales increased 1.8% during the month.
- Fiscal YTD sales are up 11% to $385.8M. The company starts lapping the EntrustRx addition in April which will push the sales growth marks lower.